Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 11;81(14):1350-1352.
doi: 10.1016/j.jacc.2023.02.014.

Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care?

Christie M Ballantyne  1 , Mini Grace Varughese  2 , Layla A Abushamat  3
Affiliations
Free article
Editorial

Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care?

Christie M Ballantyne et al. J Am Coll Cardiol. .
Free article
No abstract available

Keywords: cardiovascular disease; combination therapy; elderly; lipid-lowering therapy; secondary prevention.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Ballantyne has received grant/research support through his institution from Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, Ionis, Merck, Novartis, and Regeneron; is a consultant for Alnylam Pharmaceuticals, Althera, Amarin, Amgen, Arrowhead, AstraZeneca, Esperion, Illumina, Matinas BioPharma Inc, Merck, New Amsterdam, Novartis, Pfizer, Regeneron, and Roche Diagnostic; and has received consulting fees from 89Bio, Abbott Diagnostics, Alnylam Pharmaceuticals, Althera, Amarin, Amgen, Arrowhead, AstraZeneca, Denka Seiken, Esperion, Genentech, Gilead, Illumina, Matinas BioPharma Inc, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, and Roche Diagnostic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Comment on

Substances

LinkOut - more resources